Vanda Pharmaceuticals Incorporated (Nasdaq: VNDA), a global biopharmaceutical company, announced yesterday that it has named Timothy Williams as its new senior vice president, general counsel and secretary.
Prior to joining Vanda, Williams served as executive vice president, general counsel, chief compliance officer and corporate secretary at AgNovos Healthcare. Prior to this position, he was senior legal counsel and assistant secretary at Stryker Corporation where he led the legal department's global M&A, corporate governance, and securities groups. Before joining Stryker, he practiced law in Chicago at Mayer Brown LLP and Bryan Cave LLP.
Mihael H Polymeropoulos, MD, president and CEO of Vanda, said, 'I am very pleased to welcome Tim to the Vanda executive management team. He is an exceptional leader and lawyer and brings a wealth of experience that we expect will prove instrumental as we continue to execute our global strategy.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer